Sarca Drug Private Limited
About Sarca Drug Private Limited
Data last updated:
Sarca Drug Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2018PTC115460. Its GSTIN is 29ABACS6813P1ZQ (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Satyanarayana Yarakaraju and Apsana Ibrahim Mujawar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 4/3 Ground Floor 3rd Cross 3rd Main Srs Road Peenya New Extention, Bangalore, Karnataka, India – 560058.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.31 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹1.03 Lakh (net margin -5.7%) and EBITDA of -₹97,583 (EBITDA margin -5.3%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 29% over five years.
Company details
Contact details
Sarca Drug Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address# 4/3 Ground Floor 3rd Cross 3rd Main Srs Road Peenya New Extention, Bangalore, Karnataka, India – 560058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sarca Drug Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sarca Drug is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Sarca Drug Private Limited, buy the company report.
Financials of Sarca Drug Private Limited
FY 2025 filings availableSarca Drug Private Limited reported revenue of ₹18.31 Lakh (down 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 29%. EBITDA fell 301% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹97,583 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.3% | ||||
| Net Profit Margin | -5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sarca Drug Private Limited, buy the company report.
Board of directors of Sarca Drug Private Limited
Sarca Drug has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Yarakaraju | Director | 13 Aug 2018 | 8 Years 2 Months | Current |
| Apsana Ibrahim Mujawar | Director | 13 Aug 2018 | 8 Years 2 Months | Current |
| Narasaiahnapalya Puttanarasaiah Ramesh | Director | 02 Jun 2023 | 3 Years 5 Months | Current |
Peer comparison
Sarca Drug Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nuvo Industries Private Limited | ₹18.39 Lakh (FY 2025) | -73.0% | Bahadurgarh, Haryana, India | |||
| Brennon Drugs Private Limited | ₹18.39 Lakh (FY 2024) | 32.0% | Mumbai, Maharashtra, India | |||
| Acm Trading India Private Limited | ₹18.37 Lakh (FY 2024) | 22.0% | Bengaluru, Karnataka, India | |||
| SVPL Mining Equipments Private Limited | ₹18.37 Lakh (FY 2025) | 29.0% | Kolkata, West Bengal, India | |||
| Fitness Nest Private Limited | ₹18.34 Lakh (FY 2025) | -49.0% | New Delhi, Delhi, India | |||
| Sarca Drug Private Limitedthis company | ₹18.31 Lakh (FY 2024) | -₹1.03 Lakh | -5.7% | -12.0% | Bangalore, Karnataka, India | |
| Extension Multitrading Private Limited | ₹18.31 Lakh (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Nereus Enterprises Private Limited | ₹18.31 Lakh (FY 2024) | 26.0% | Delhi, India | |||
| Vexcolt Infra Projects Private Limited | ₹18.3 Lakh (FY 2025) | 79.0% | Delhi, India | |||
| Medismart Pharmaceutical Private Limited | ₹18.3 Lakh (FY 2025) | -59.0% | Delhi, India | |||
| P A Imports Private Limited | ₹18.3 Lakh (FY 2025) | -65.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Sarca Drug Private Limited, buy the company report.
Auditor
Sarca Drug Private Limited is audited by PRASANNA KUMARA M G & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRASANNA KUMARA M G & CO | FY 2021 | 017297S |
Shareholding
The shareholding of Sarca Drug Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sarca Drug Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sarca Drug Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sarca Drug Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sarca Drug has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABACS6813P1ZQ | Karnataka | Active | 11 Sep 2018 |
To see the full GST registrations and return filing status of Sarca Drug Private Limited, buy the company report.
Recent activity
Sarca Drug Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Sripathy Shanbhog ceased to be Additional Director on 28 Feb 2025.
Frequently asked questions
Sarca Drug is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 2018 (8+ years old) and is registered under CIN U51909KA2018PTC115460.
Sarca Drug has 3 current directors:
- Satyanarayana Yarakaraju - Director
- Apsana Ibrahim Mujawar - Director
- Narasaiahnapalya Puttanarasaiah Ramesh - Director
The latest financial statements of Sarca Drug on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Sarca Drug is 29ABACS6813P1ZQ, registered in Karnataka.
The CIN (Corporate Identification Number) of Sarca Drug is U51909KA2018PTC115460. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sarca Drug was incorporated on 13 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Sarca Drug by revenue are Nuvo Industries Private Limited, Brennon Drugs Private Limited, Acm Trading India Private Limited, SVPL Mining Equipments Private Limited, Fitness Nest Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Sripathy Shanbhog ceased to be Additional Director on 28 Feb 2025. Narasaiahnapalya Puttanarasaiah Ramesh ceased to be Additional Director on 26 Apr 2024. Narasaiahnapalya Puttanarasaiah Ramesh was appointed as Director on 02 Jun 2023. Sarca Drug has 6 board changes on record in total.
The registered office of Sarca Drug is at # 43 Ground Floor 3rd Cross 3rd Main Srs Road Peenya New Extention, Bangalore, Karnataka, India – 560058.
Sarca Drug operates in the pharma industry, in the drug formulation and development segment.
Sarca Drug can be reached at its registered office: # 43 Ground Floor 3rd Cross 3rd Main Srs Road Peenya New Extention, Bangalore, Karnataka, India – 560058.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
